Business Brief -- Diagnostic Products Corp.:
   Los Angeles Concern Agrees
   To Buy Cirrus Diagnostic
Diagnostic Products said the number of shares to be paid
will be based on the average trading price of its stock in
the 10 days preceding the agreement. The maker of medical
diagnostic test kits said it hopes to complete the deal by
early June.
   In New York Stock Exchange composite trading Friday,
Diagnostic Products closed at $32.375, up 37.5 cents.